Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
14.4M
-
Shares change
-
-3.17M
-
Total reported value, excl. options
-
$363M
-
Value change
-
-$79.1M
-
Number of buys
-
35
-
Number of sells
-
-24
-
Price
-
$25.50
Significant Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA) as of Q3 2018
68 filings reported holding KNSA - Kiniksa Pharmaceuticals Intern - COM as of Q3 2018.
Kiniksa Pharmaceuticals Intern - COM (KNSA) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.4M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (3M shares), Hillhouse Capital Management, Ltd. (1.39M shares), ArrowMark Colorado Holdings LLC (1.19M shares), BOXER CAPITAL, LLC (1.17M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.06M shares), Sofinnova Ventures Inc (923K shares), Cormorant Asset Management, LP (831K shares), FMR LLC (778K shares), VHCP Management II, LLC (639K shares), and Vanguard Group Inc (556K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.